Dr. Zhu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
505 Parnassus Avenue
San Francisco, CA 94143
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2020 - 2023
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2017 - 2020
Shanghai Jiao Tong University School of MedicineClass of 2011
Certifications & Licensure
CA State Medical License 2020 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Androgen receptor inhibition increases MHC Class I expression and improves immune response in prostate cancer.Lisa N Chesner, Fanny Polesso, Julie N Graff, Jessica E Hawley, Alexis K Smith
Cancer Discovery. 2024-12-05 - 2 citationsAn Atlas of Accessible Chromatin in Advanced Prostate Cancer Reveals the Epigenetic Evolution during Tumor Progression.Raunak Shrestha, Lisa N Chesner, Meng Zhang, Stanley Zhou, Adam Foye
Cancer Research. 2024-09-16 - Genomic and transcriptomic features of androgen receptor signaling inhibitor resistance in metastatic castration-resistant prostate cancer.Xiaolin Zhu, Tatyanah Farsh, Daniël Vis, Ivan Yu, Haolong Li
The Journal of Clinical Investigation. 2024-08-13
Journal Articles
- De Novo and Inherited Private Variants in MAP1B in Periventricular Nodular HeterotopiaAnnapurna Poduri, Xiaolin Zhu, William B Dobyns, Christopher A Walsh, PLoS One
Press Mentions
Researcher Develops Town-Level Model for COVID-19 in ConnecticutJanuary 27th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
